The Effect of a Web-Based Breastfeeding Education Program for Adolescent Pregnant

The Effect of a Web-Based Breastfeeding Education Program for Adolescent Pregnant Women in the Third Trimester on Breastfeeding Practices: Randomized Controlled Trial

It is crucial to prepare adolescent mothers-who represent a vulnerable group where the importance of breastfeeding is increasingly emphasized-for the breastfeeding process. One potential method for promoting breastfeeding is through web-based education interventions. The aim of this study was to evaluate the effect of a web-based breastfeeding education program, developed by the researchers, on breastfeeding outcomes among adolescent pregnant women in the postpartum period. This randomized controlled study involved a sample of 100 pregnant adolescents, aged 15-19 years, who were in their third trimester of pregnancy. The study commenced after obtaining ethical approval and permissions from the hospital where the research was conducted.

A web-based breastfeeding education program was administered to the experimental group. Data were collected using a Socio-Demographic Data Form, the Breastfeeding Self-Efficacy Scale Short Form (Antenatal Version), the Breastfeeding Self-Efficacy Scale Short Form (Postnatal Version), and the LATCH Breastfeeding Diagnosis and Assessment Scale. Data collection occurred during the third trimester (pretest) and the 1st and 8th postnatal weeks (posttest).

Study Overview

• Status: Completed
• Conditions: Breastfeeding
• Intervention / Treatment: Behavioral: web based education

• Study Type: Interventional
• Enrollment (Actual): 90
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Turkey
  • VAN, Turkey, 65000
    • Van Yuzuncu Yıl University
  • Tuşba
    • VAN, Tuşba, Turkey, 65000
      • Van Yuzuncu Yıl University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Aged between 15 and 19 years
• Had not previously received planned breastfeeding education
• Were between 28 and 37 weeks gestation (third trimester)
• Gave birth at term
• Had no health issues preventing breastfeeding
• Could read, write, and respond to questions
• Had access to a computer, tablet, or smartphone, and had regular internet access.

Exclusion Criteria:

• Participants were excluded if they had multiple pregnancies
• Physical or mental health problems, communication disabilities
• A history of breast surgery
• İf their newborns were considered high-risk.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Health Services Research
• Allocation: Randomized
• Interventional Model: Crossover Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: control; no intervention
Experimental: experimental; web based education	Behavioral: web based education; web based education

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Breastfeeding self-efficacy scale	Breastfeeding self-efficacy scale	pre-test post-test (approximately six month)

Collaborators and Investigators

• Sponsor: Yuzuncu Yıl University

Study record dates

Study Major Dates

• Study Start (Actual): August 19, 2024
• Primary Completion (Actual): November 25, 2024
• Study Completion (Actual): November 25, 2024

Study Registration Dates

• First Submitted: November 19, 2024
• First Submitted That Met QC Criteria: December 9, 2024
• First Posted (Estimated): December 13, 2024

Study Record Updates

• Last Update Posted (Estimated): December 13, 2024
• Last Update Submitted That Met QC Criteria: December 9, 2024
• Last Verified: December 1, 2024

More Information

Terms related to this study

• Other Study ID Numbers: WEB TABAN

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No